Mark R. Ziebell
2019
Compensation breakdown
| Non-Equity Incentive Plan | $82,407 |
|---|---|
| Salary | $361,920 |
| Other | $40,727 |
| Total | $485,054 |
Ziebell received $361.9K in salary, accounting for 75% of the total pay in 2019.
Ziebell also received $82.4K in non-equity incentive plan and $40.7K in other compensation.
Rankings
In 2019, Mark R. Ziebell's compensation ranked 11,847th out of 13,971 executives tracked by ExecPay. In other words, Ziebell earned more than 15.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,847 out of 13,971 | 15th |
Division Manufacturing | 4,794 out of 5,695 | 16th |
Major group Chemicals And Allied Products | 1,891 out of 2,194 | 14th |
Industry group Drugs | 1,629 out of 1,880 | 13th |
Industry Pharmaceutical Preparations | 1,209 out of 1,392 | 13th |
Pay ratio
| Mark R. Ziebell's Pay | $485,054 |
|---|---|
| Median Employee's Pay | $96,570 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Mark R. Ziebell was $485,054.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $96,570.
The ratio of Mark R. Ziebell's pay to the pay of median employee was therefore 5 to one.
Ziebell's colleagues
We found four more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2019.
2019
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
2019
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
2019
Stephen Hedberg
Peregrine Pharmaceuticals
Principal Financial Officer and Principal Accounting Officer
2019
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019
August 17, 2018